{
  "ticker": "AVE",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02973691",
  "id": "02973691",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250729",
  "time": "0908",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250729/pdf/06m7rcfkg0z4w9.pdf",
  "summary": "**Key Material Information (Clinical Trial Update):**  \n\n- **Patient Recruitment Progress:** 131 patients dosed out of 210 required for interim analysis.  \n- **Timeline:** Interim analysis recruitment completion expected H2 2025, results anticipated early 2026.  \n- **Trial Expansion:** Activation of new sites (Sydney, Gold Coast) accelerated recruitment.  \n\n*No other material trading/capital markets information identified.*",
  "usage": {
    "prompt_tokens": 2424,
    "completion_tokens": 88,
    "total_tokens": 2512,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-28T23:29:31.792738"
}